Faculty - Renée JG Arnold PharmD, RPh
This module is an introduction to the role of cost-consequence (CC)/cost-minimization analysis(CMA) in medical decision making from multiple perspectives. It will describe situations in which CCA/CMA is the acceptable method of pharmacoeconomic (PE) analysis, the components included, computational methods, the concept of efficacy vs. effectiveness and establishing equivalent outcomes.
By the end of the Cost-Minimization/Cost-Consequence (CMA/CCA) module, you will be able to:
- State the role of cost-consequence (CC)/cost-minimization analysis (CMA) in medical decision making.
- Contrast the price of a drug product and the cost of drug therapy.
- Define the components of CC/CMA.
- Understand the computations involved in CC/CMA.
- Understand the concerns in attribution of cost components to a particular treatment arm.
- Summarize the resources used in a therapy or service and assign monetary values to those resources.
- Analyze the value for money from health technologies.
- Summarize how CC/CMA are used in health policy decisions regarding government approval of and reimbursement for therapies.
- Use and apply sensitivity analyses and discounting techniques in CC/CMA.
- Explain how point of view and perspective affect CC/CMA.